Aurore Keutgens
Overview
Explore the profile of Aurore Keutgens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rulmont J, Tassin F, Keutgens A
Rev Med Liege
. 2024 Mar;
79(3):137-142.
PMID: 38487906
VEXAS syndrome is a new entity, described as the first one of a new class of hemato-inflammatory diseases. Through this article and based on the first case highlighted at the...
2.
Pitti P, Tassin F, Keutgens A
Ann Biol Clin (Paris)
. 2023 Mar;
81(2):189-197.
PMID: 36941226
Malaria is a potentially severe disease, particularly in Africa. In Europe, the majority of malaria cases come from travelers returning from endemic areas. The non-specific symptomatology may not alert the...
3.
Nizet A, Foguenne J, Gothot A, Tassin F, Keutgens A
Int J Lab Hematol
. 2021 Apr;
43(5):e264-e265.
PMID: 33881804
No abstract available.
4.
Wera O, Lecut C, Servais L, Hego A, Delierneux C, Jiang Z, et al.
J Thromb Haemost
. 2019 Aug;
18(1):44-56.
PMID: 31448510
Background: Intestinal inflammation is associated with bleeding and thrombosis, two processes that may involve both platelets and neutrophils. However, the mechanisms and the respective contribution of these cells to intestinal...
5.
Keutgens A, Foguenne J, Gothot A, Tassin F
Ann Biol Clin (Paris)
. 2016 Apr;
74(2):168-75.
PMID: 27029722
Monoclonal B-cell lymphocytosis (MBL) is defined as an asymptomatic condition characterized by the presence of less than 5,000 monoclonal B-cells per microliter and the absence of clinical signs or symptoms...
6.
Keutgens A, Foguenne J, Gothot A, Tassin F
Ann Biol Clin (Paris)
. 2015 Dec;
73 Suppl 1:17-8.
PMID: 26620239
No abstract available.
7.
Caers J, Hafraoui K, Keutgens A, Caberg J, Lambert F, Tassin F, et al.
Eur J Haematol
. 2013 Dec;
92(2):179-80.
PMID: 24299333
No abstract available.
8.
Keutgens A, Simoni P, Detrembleur N, Frippiat F, Giot J, Spirlet F, et al.
J Clin Microbiol
. 2012 Nov;
51(2):688-91.
PMID: 23175265
For the last 10 years, the southern part of Belgium has been recognized as a low-risk area of endemicity for alveolar echinococcosis. This infection, caused by Echinococcus multilocularis, usually induces...
9.
Keutgens A, Zhang X, Shostak K, Robert I, Olivier S, Vanderplasschen A, et al.
J Biol Chem
. 2010 Jun;
285(33):25831-40.
PMID: 20558726
The oncogenic protein BCL-3 activates or represses gene transcription through binding with the NF-kappaB proteins p50 and p52 and is degraded through a phospho- and GSK3-dependent pathway. However, the mechanisms...
10.
Keutgens A, Shostak K, Close P, Zhang X, Hennuy B, Aussems M, et al.
Mol Cell Biol
. 2010 Jun;
30(16):4006-21.
PMID: 20547759
The nuclear and oncogenic BCL-3 protein activates or represses gene transcription when bound to NF-kappaB proteins p50 and p52, yet the molecules that specifically interact with BCL-3 and drive BCL-3-mediated...